Groupe
Grimaud
The Group’s
business lines and expertise
GENETIC SELECTION
Harnessing cutting-edge technologies and more than 50 years of expertise in animal genetics, we naturally select the best-performing and longest-lasting breeding animals in order to meet the various expectations of breeding farmers and consumers on global markets. We provide a technical support and related services for animal management, enabling them to make the most of their genetic potential.
Biopharmacy
Buoyed by our genetic selection knowledge, we are expanding human and animal biopharmacy operations. With human and animal health in mind, we are creating and selling vaccines, autovaccines, probiotics and pharmaceutical raw materials.
Novel Farming
We are keeping a firm eye on forward developments in livestock breeding Fields and are exploring pioneering projects to make our Breeding more sustainable and successful, such as precision farming and additional sources of animal protein (such as cellular meat and insect protein).
Join us
We are recruiting employees for all of the Group’s subsidiaries. Whether you are looking for a role as a production employee, a manager or a support worker, there will definitely be a job for you within our Group.
Groupe Grimaud in 4 numbers
Year that the Group was founded
M€ in turnover and royalties
%
of its turnover from abroad
employees of more than 30 nationalities speaking 18 languages
news
Follow our latest news
NOVOGEN: Successful start for the new hatchery
Novogen renovated the hatchery with state-of-the-art equipment to comply with its strategy of excellence in the quality of products delivered.
GROUPE GRIMAUD IS PLANNING ELECTRICITY SELF-CONSUMPTION!
Groupe Grimaud is strengthening its green energy production with 3 new photovoltaic power plant projects for self-consumption.
NOVOGEN REDUCES ITS FUEL CONSOMPTION
Novogen is improving the carbon impact of its transport fleet by acquiring new vehicles.
Follow our latest news
Stay in contact with Groupe Grimaud and receive our latest updates.
GENETECH,
GROUPE GRIMAUD’S RESEARCH POWERHOUSE
